TY - JOUR
T1 - Inhibition of the Na+-K+-2Cl--cotransporter in choroid plexus attenuates traumatic brain injury-induced brain edema and neuronal damage
AU - Lu, Kwok-Tung
AU - Wu, Chang Yen
AU - Cheng, Nai Chi
AU - Wo, Yu Yuan Peter
AU - Yang, Jen Tsung
AU - Yen, Hao Han
AU - Yang, Yi Ling
N1 - Funding Information:
The authors wish to thank Dr. Jeng-Hsiung F. Peng for his editorial assistance. This work was supported by grants from the National Science Council, Taiwan (NSC 93-2320-B-415-001 and 94-2320-B-005-025).
PY - 2006/10/24
Y1 - 2006/10/24
N2 - The present study was aimed to elucidate the possible role of Na+-K+-2Cl--cotransporter (NKCC1) on traumatic brain injury-induced brain edema, cerebral contusion and neuronal death by using traumatic brain injury animal model. Contusion volume was verified by 2,3,5,-triphenyltetrazolium chloride monohydrate staining. NKCC1 mRNA expression was detected by RT-PCR and the protein expression of NKCC1 was measured by Western blot. We found that the expression of NKCC1 RNA and protein were up-regulated in choroid plexus apical membrane from 2 h after traumatic brain injury, peaked at 8 h, and lasted for 24 h. Rats in the experimental group displayed severe brain edema (water content: 81.45 ±0.32% compared with 78.38 ± 0.62% of sham group) and contusion volume significantly increased 8 h after traumatic brain injury (864.14 ±28.07 mm3). Administration of the NKCC1 inhibitor bumetanide (15 mg/kg, I.V.) significantly attenuated the contusion volume (464.03 ±23.62 mm3) and brain edema (water content: 79.12 ± 0.28%) after traumatic brain injury. Our study demonstrates that NKCC1 contributes to traumatic brain injury-induced brain edema and neuronal damage.
AB - The present study was aimed to elucidate the possible role of Na+-K+-2Cl--cotransporter (NKCC1) on traumatic brain injury-induced brain edema, cerebral contusion and neuronal death by using traumatic brain injury animal model. Contusion volume was verified by 2,3,5,-triphenyltetrazolium chloride monohydrate staining. NKCC1 mRNA expression was detected by RT-PCR and the protein expression of NKCC1 was measured by Western blot. We found that the expression of NKCC1 RNA and protein were up-regulated in choroid plexus apical membrane from 2 h after traumatic brain injury, peaked at 8 h, and lasted for 24 h. Rats in the experimental group displayed severe brain edema (water content: 81.45 ±0.32% compared with 78.38 ± 0.62% of sham group) and contusion volume significantly increased 8 h after traumatic brain injury (864.14 ±28.07 mm3). Administration of the NKCC1 inhibitor bumetanide (15 mg/kg, I.V.) significantly attenuated the contusion volume (464.03 ±23.62 mm3) and brain edema (water content: 79.12 ± 0.28%) after traumatic brain injury. Our study demonstrates that NKCC1 contributes to traumatic brain injury-induced brain edema and neuronal damage.
KW - Brain edema
KW - Bumetanide
KW - Na-K-2Cl cotransporter
KW - Traumatic brain injury
UR - http://www.scopus.com/inward/record.url?scp=33748714959&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748714959&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2006.07.048
DO - 10.1016/j.ejphar.2006.07.048
M3 - Article
C2 - 16962576
AN - SCOPUS:33748714959
VL - 548
SP - 99
EP - 105
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
SN - 0014-2999
IS - 1-3
ER -